July 14, 2014 8:08 AM ET

Biotechnology

Company Overview of Peninsula Pharmaceuticals Inc.

Company Overview

Peninsula Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the licensing, development, and commercialization anti-infective therapies for the treatment of patients with life-threatening infections for the North American and European markets. Its lead product candidate, doripenem for injection, is an intravenous broad-spectrum antibiotic for the treatment of infections in hospitalized patients, which completed phase II trial. The company also has two additional antibiotics in development, including doripenem for inhalation for the management of pulmonary infections in cystic fibrosis patients; and PPI-0903, an intravenous broad-spectrum antibiotic for the treatment of sev...

1751 Harbor Bay Parkway

Alameda, CA 94502

United States

Founded in 2001

21 Employees

Phone:

510-747-3900

Key Executives for Peninsula Pharmaceuticals Inc.

Chief Financial Officer and Principal Accounting Officer
Age: 48
Vice President of Pharmaceutical Chemistry and Product Development
Age: 50
Vice President of Preclinical and Clinical Sciences
Age: 54
Vice President of Commercial Development
Age: 43
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
SpringLeaf Therapeutics, Inc. United States
Chantal Pharmaceutical United States
Moerae Matrix, Inc. United States
Cardinal Health 404, Inc. United States
GX Healthcare LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Peninsula Pharmaceuticals Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.